You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

  1. NANOMETER-SIZE STEP HEIGHT TEST STRUCTURES

    SBC: Advanced Technologies/Laboratories Intl            Topic: N/A

    MCNC PROPOSES A FEASIBILITY STUDY AND EVALUATION OF THREE PROMISING APPROACHES TO THE FABRICATION OF SURFACE TEST STRUCTURES ON SILICON. SURFACE FEATURES ON THE FIRST STRUCTURE WILL BE PRODUCED BY CONTROLLABLY ETCHING THERMALLYGROWN OXIDES. FEATURES ON THE SECOND WILL BE MADE BY ETCHING PIEZOELECTRIC THIN FILMS. USING THE PIEZOELECTRIC FILM AS PART OF A CAPACITOR, STEP-HEIGHT CAN BE VARIED AND PRO ...

    SBIR Phase I 1992 Department of Commerce
  2. Electro-Immunosensor for Regulating/Achieving Fertility

    SBC: ALDERON BIOSCIENCES, INC.            Topic: N/A

    N/A

    SBIR Phase I 1992 Department of Health and Human Services
  3. Electro-immunosensor to Detect Cocaine & THC Metabolite

    SBC: ALDERON BIOSCIENCES, INC.            Topic: N/A

    N/A

    SBIR Phase I 1992 Department of Health and Human Services
  4. DEMONSTRABLY CORRECT COMPILATION (DCC)

    SBC: Baldwin/mchugh Assoc., Inc.            Topic: N/A

    A TECHNIQUE FOR OBTAINING TRUSTWORTHY COMPILATION BASED ON A COMPILATION CHECKER (SIMILAR TO A PROOF CHECKER) IS PROPOSED. THE TRANSFORMATIONS USED IN A COMPILER WILL BE FORMALLY SPECIFIED AND VERIFIED USING INTERPRETER EQUIVALENCE METHODS. THE COMPILER WILL BE INSTRUMENTED TO PRODUCE A TRACE OF THE TRANSFORMATIONS APPLIED IN THE COMPILATION OF A GIVEN PROGRAM. THE COMPILATION CHECKER WILL VALIDAT ...

    SBIR Phase I 1992 Department of DefenseDefense Advanced Research Projects Agency
  5. RAPID FIBRINOGEN ASSAY FOR USE IN THROMBOLYTIC THERAPY

    SBC: Biotherm, Inc.            Topic: N/A

    AN ASSAY SYSTEM FOR MONITORING FUNCTIONAL FIBRINOGEN IN PATIENTS UNDERGOING THROMBOLYTIC THERAPY WILL BE DEVELOPED. THIS SYSTEM WILL BE BASED ON A NOVEL DRY REAGENT ASSAY TECHNOLOGY THAT HAS RECENTLY BEEN APPLIED SUCCESSFULLY TO PTAND ACTIVATED PTT TESTS. INTRODUCTION OF A RAPID, CONVENIENT, FIBRINOGEN ASSAY SYSTEM ON A DECENTRALIZED BASISCOULD PROVIDE ACCURATE RESULTS SOONER THAN EXISTING LABORAT ...

    SBIR Phase II 1992 Department of Health and Human Services
  6. HYBRID DIFFRACTIVE/REFRACTIVE RELAY SYSTEM FOR HEAD MOUNTED DISPLAYS

    SBC: DIGITAL OPTICS CORP.            Topic: N/A

    N/A

    SBIR Phase I 1992 Department of DefenseDefense Advanced Research Projects Agency
  7. PURIFICATION OF A FIBRINOLYSIS ENHANCING PROTEIN

    SBC: Elcatech, Inc.            Topic: N/A

    DURING THE DEVELOPMENT OF OUR FIBRINOLYTIC ASSAY SYSTEM WE NOTED AN ENHANCEMENT OF FIBRINOLYTIC ACTIVITY IN PLASMA WHICH COULD NOT BE ACCOUNTED FOR BY ANY KNOWN FIBRINOLYTIC FACTOR. USING HEPARING AFFINITY CHROMATOGRAPHY, WITH A 0.5M NAC1 ELUTION AND AN IMMUNO AFFINITY COLUMN WE HAVE BEEN ABLE TO PARTIALLY PURIFY THIS FACTOR. THE IMMUNO AFFINITY COLUMN USES IMMOBILIZED MCAB-3, A MONOCLONAL ANTIBOD ...

    SBIR Phase I 1992 Department of Health and Human Services
  8. NOVEL ACTIVITY AND IMMUNOASSAYS FOR PAI-1

    SBC: Elcatech, Inc.            Topic: N/A

    PLASMINOGEN ACTIVATION IS MODULATED BY A NUMBER OF INHIBITORS. THE FAST ACTING INHIBITOR OF T-PA AND U-PA HAS BEEN DESIGNATED PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1). THE DETECTION OF RAISED LEVELS OF THIS ACUTE PHASE PROTEIN IS INDICATIVE OF AN IMBALANCE IN THE HEMOSTATIC SYSTEM. IN ORDER TO FULLY ASSESS PAI-1 PLASMA LEVELS IT IS NECESSARY TO MEASURE THE PROTEIN BY BOTH ANTIGENIC AND ACTIVITY A ...

    SBIR Phase I 1992 Department of Health and Human Services
  9. ELDERS' COMPREHENSION AND ACCEPTANCE OF HEALTH EDUCATION

    SBC: Eldersource Inc.            Topic: N/A

    N/A

    SBIR Phase I 1992 Department of Health and Human Services
  10. MOLECULAR ANALYSIS OF DELETION MUTATIONS

    SBC: Environmental Health Research            Topic: N/A

    THE OBJECTIVE IS THE DEVELOPMENT OF METHODS AND REAGENTS FOR USE IN THE STUDY OF DELETION MUTATIONS AT THE MOLECULAR LEVEL. SUCH TECHNOLOGY HAS NOT BEEN DEVELOPED FOR THE ANALYSIS OF DELETION MUTATIONS WHICH ARE INDUCED BY AN IMPORTANT CLASS OF ENVIRONMENTAL MUTAGENS/CARCINOGENS AND IS NECESSARY FOR THE ASSESSMENT OF POTENTIAL HAZARD TO MAN FROM THESE COMPOUNDS, THE HYPOXANTHINE GUANINE PHOSPHORIB ...

    SBIR Phase I 1992 Department of Health and Human Services
US Flag An Official Website of the United States Government